title: [Hemosorption in multimodal treatment of endogenous uveitis].
abstract: Hemoperfusion was used in multiple modality treatment of 92 patients with chronic recurrent endogenic uveitis and uveitis associated with syndromic conditions. The treatment included systemic and local steroids, and antiinflammatory therapy. Clinical improvement was achieved in 75 percent of patients; it was paralleled by improvement of the vision acuity. In the rest patients vision acuity was unchanged because of irreversible impairment of the retina and optic nerve, but uveitis ceased. Addition of hemoperfusion of multiple-modality treatment of uveitis patients resulted in shortening of hospital stay by 6-7 days, in prolongation of remission periods to 10-15 months after a single course of hemoperfusion in 71 percent of patients and after two courses in the rest. A dynamic immunologic analysis has shown normalization of T lymphocyte functional activity, and of blood serum immunoglobulin and circulating immune complexes levels.
authors.forename: L A
authors.initials: LA
authors.lastname: Katsnel'son
authors.forename: A F
authors.initials: AF
authors.lastname: Kaliberdina
authors.forename: V E
authors.initials: VE
authors.lastname: Tankovskiĭ
authors.forename: L E
authors.initials: LE
authors.lastname: Teplinskaia
authors.forename: O S
authors.initials: OS
authors.lastname: Slepova
authors.forename: A A
authors.initials: AA
authors.lastname: Dmitriev
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006464:Hemoperfusion; D006801:Humans; D008297:Male; D012008:Recurrence; D013997:Time Factors; D014605:Uveitis / Q000188:drug therapy / Q000628:therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents
vernacular_title: Gemosorbtsiia v kompleksnom lechenii éndogennykh uveitov.